Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Receivables - Other (2016 - 2025)

BioCorRx's Receivables - Other history spans 10 years, with the latest figure at $761515.0 for Q3 2025.

  • For Q3 2025, Receivables - Other rose 142.39% year-over-year to $761515.0; the TTM value through Sep 2025 reached $761515.0, up 142.39%, while the annual FY2023 figure was $76266.0, 37.82% down from the prior year.
  • Receivables - Other for Q3 2025 was $761515.0 at BioCorRx, up from $153728.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $958111.0 in Q2 2022 and bottomed at $1500.0 in Q1 2021.
  • The 5-year median for Receivables - Other is $101081.0 (2023), against an average of $245775.3.
  • The largest annual shift saw Receivables - Other soared 63774.07% in 2022 before it tumbled 99.24% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $56359.0 in 2021, then soared by 117.63% to $122652.0 in 2022, then crashed by 37.82% to $76266.0 in 2023, then soared by 311.94% to $314170.0 in 2024, then surged by 142.39% to $761515.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Receivables - Other are $761515.0 (Q3 2025), $153728.0 (Q2 2025), and $153360.0 (Q1 2025).